ATE118758T1 - Derivate von endogenen mediatoren, ihre salze, verfahren zur herstellung, anwendungen und zusammensetzungen, die diese enthalten. - Google Patents

Derivate von endogenen mediatoren, ihre salze, verfahren zur herstellung, anwendungen und zusammensetzungen, die diese enthalten.

Info

Publication number
ATE118758T1
ATE118758T1 AT91430009T AT91430009T ATE118758T1 AT E118758 T1 ATE118758 T1 AT E118758T1 AT 91430009 T AT91430009 T AT 91430009T AT 91430009 T AT91430009 T AT 91430009T AT E118758 T1 ATE118758 T1 AT E118758T1
Authority
AT
Austria
Prior art keywords
preparation
derivatives
salts
endogene
mediators
Prior art date
Application number
AT91430009T
Other languages
English (en)
Inventor
Jacques Chauveau
Michel Delaage
Anne Morel
Louis Segu
Original Assignee
Immunotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9006292A external-priority patent/FR2662082B1/fr
Priority claimed from FR9101292A external-priority patent/FR2671971B1/fr
Application filed by Immunotech Sa filed Critical Immunotech Sa
Application granted granted Critical
Publication of ATE118758T1 publication Critical patent/ATE118758T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
AT91430009T 1990-05-15 1991-05-13 Derivate von endogenen mediatoren, ihre salze, verfahren zur herstellung, anwendungen und zusammensetzungen, die diese enthalten. ATE118758T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9006292A FR2662082B1 (fr) 1990-05-15 1990-05-15 Nouveaux derives de mediateurs endogenes, leurs sels, procede de preparation et applications.
FR9101292A FR2671971B1 (fr) 1991-01-30 1991-01-30 Nouveaux derives de la serotonine, application a titre de medicament et compositions les renfermant.

Publications (1)

Publication Number Publication Date
ATE118758T1 true ATE118758T1 (de) 1995-03-15

Family

ID=26228029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91430009T ATE118758T1 (de) 1990-05-15 1991-05-13 Derivate von endogenen mediatoren, ihre salze, verfahren zur herstellung, anwendungen und zusammensetzungen, die diese enthalten.

Country Status (12)

Country Link
US (1) US5298491A (de)
EP (1) EP0457701B1 (de)
JP (1) JP2968623B2 (de)
KR (1) KR0138750B1 (de)
AT (1) ATE118758T1 (de)
AU (1) AU650265B2 (de)
CA (1) CA2042295A1 (de)
DE (1) DE69107512T2 (de)
DK (1) DK0457701T3 (de)
ES (1) ES2039313T3 (de)
IE (1) IE67888B1 (de)
NO (1) NO308663B1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW288010B (de) * 1992-03-05 1996-10-11 Pfizer
ATE148465T1 (de) * 1992-04-10 1997-02-15 Pfizer Acylaminoindolderivate als 5-ht1 agonisten
TW251284B (de) * 1992-11-02 1995-07-11 Pfizer
FR2699918B1 (fr) * 1992-12-30 1995-03-17 Pf Medicament Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments.
JPH08511794A (ja) * 1993-06-18 1996-12-10 ハフスルント ニコムド エイ／エス ▲ｖｉｉ▼因子由来ペプチド
CA2259927A1 (en) 1996-07-12 1998-01-22 Leukosite, Inc. Chemokine receptor antagonists and methods of use therefor
FR2773489B1 (fr) * 1998-01-15 2001-03-23 Immunotech Sa Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
KR100596641B1 (ko) * 1998-12-11 2006-10-04 이승진 진단용 공중합성 미셀 및 그의 제조방법
US7163918B2 (en) * 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
CA2490254C (en) 2002-06-21 2011-11-01 Suven Life Sciences Limited Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
BR0312175A (pt) 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso
CA2509982C (en) 2002-11-28 2011-11-08 Suven Life Sciences Limited N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
EP1567492B1 (de) 2002-11-28 2013-05-22 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindole
SI1581538T1 (sl) 2002-12-18 2007-08-31 Suven Life Sciences Ltd Tetraciklični 3-substituirani indoli z afiniteto za receptor serotonina

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703325A (en) * 1951-12-06 1955-03-01 Upjohn Co Preparation of 5-benzyloxytryptamines
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US3686213A (en) * 1970-08-28 1972-08-22 American Cyanamid Co Substituted aminoethyl indoles
US4046636A (en) * 1974-06-20 1977-09-06 Syva Company Diazepam enzyme conjugates
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays
US4040907A (en) * 1974-06-20 1977-08-09 Syva Company Iodothyronine enzyme conjugates
DE2737802A1 (de) * 1977-08-22 1979-03-08 Henning Berlin Gmbh Arzneimittel oder diagnostikum zur behandlung oder feststellung von schilddruesenfunktionsstoerungen und verfahren zu dessen herstellung
FR2437398A1 (fr) * 1978-06-20 1980-04-25 Commissariat Energie Atomique Compose iode utilisable comme traceur en radio-immunologie
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
US4426453A (en) * 1980-09-18 1984-01-17 Amersham International Limited Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds
DE3368258D1 (en) * 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
JPS60132935A (ja) * 1983-12-20 1985-07-16 Sumitomo Chem Co Ltd フエニルセリン誘導体及びその製造方法
FR2562671B1 (fr) * 1984-04-10 1986-07-25 Immunotech Sa Procede pour le dosage immunologique des monoamines
EP0225726B1 (de) * 1985-11-08 1991-04-17 Glaxo Group Limited Indolderivate
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
DE3628795A1 (de) * 1986-08-25 1988-03-03 Hoechst Ag Neue thyroninderivate
US5019586A (en) * 1987-04-14 1991-05-28 Glaxo Group Limited Ketone derivatives
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
GB8802127D0 (en) * 1988-02-01 1988-03-02 Glaxo Group Ltd Chemical compounds
US4933324A (en) * 1988-02-26 1990-06-12 Shashoua Victor E Fatty acid-neuroactive drug conjugate as a prodrug
FR2671971B1 (fr) * 1991-01-30 1994-01-28 Immunotech Nouveaux derives de la serotonine, application a titre de medicament et compositions les renfermant.
FR2662082B1 (fr) * 1990-05-15 1994-12-23 Immunotech Sa Nouveaux derives de mediateurs endogenes, leurs sels, procede de preparation et applications.

Also Published As

Publication number Publication date
AU7704591A (en) 1991-11-21
EP0457701A1 (de) 1991-11-21
IE911649A1 (en) 1991-11-20
AU650265B2 (en) 1994-06-16
CA2042295A1 (fr) 1991-11-16
NO911880D0 (no) 1991-05-14
US5298491A (en) 1994-03-29
DK0457701T3 (da) 1996-02-05
JPH04288044A (ja) 1992-10-13
NO911880L (no) 1991-11-18
KR910020034A (ko) 1991-12-19
EP0457701B1 (de) 1995-02-22
DE69107512D1 (de) 1995-03-30
KR0138750B1 (ko) 1998-05-01
IE67888B1 (en) 1996-05-01
ES2039313T1 (es) 1993-10-01
NO308663B1 (no) 2000-10-09
JP2968623B2 (ja) 1999-10-25
ES2039313T3 (es) 1995-04-16
DE69107512T2 (de) 1995-06-29

Similar Documents

Publication Publication Date Title
ATE118758T1 (de) Derivate von endogenen mediatoren, ihre salze, verfahren zur herstellung, anwendungen und zusammensetzungen, die diese enthalten.
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
BR0010555A (pt) Inibidores de neuraminidases
PT96324A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
ES2115096T3 (es) Derivados tetrazolicos de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
DK130883D0 (da) Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater
BR9813022A (pt) Derivados de ésteres hidroxiacéticos, seu processo de preparação e sua utilização como intermediários de sìntese
PT80683A (de) Verfahren zur herstellung von neue n-(2-nitrophenyl)-2-amino-pyrimidin-derivate
BR0011738A (pt) Derivados de benzeno, processo para a preparação dos mesmos e composições farmacêuticas que os contêm
ES2052166T3 (es) Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
ATE38834T1 (de) 5-substituierte 1,2,4-oxadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AT384424B (de) Verfahren zur herstellung von neuen 3-hydroxy-2-oxo-pyrrolidinderivaten und ihren salzen
FR2354091A1 (fr) Utilisation d'esters aliphatiques d'acide 2-methyl-2-alkylalcanoiques comme matieres aromatiques et compositions de parfums en contenant
ES2022446B3 (es) Derivados fenolicos de benzotiazol y su aplicacion como inhibidores de corrosion.
ATE279411T1 (de) Fluorszierende marker
PT83725B (pt) Processo para preparacao de novos derivados da 3-oxadiol-beta-carbolina e 3-carboxilato-beta-carbolina e de composicoes farmaceuticas que os contem
ATE62222T1 (de) Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.
ES2098570T3 (es) Amidas de un acido 4-amino-2-ureido-pirimidina-5-carboxilico, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.
US3885948A (en) Meta-substituted ether anilides as algicidal agents
BR0003021A (pt) Processo para a preparação de um composto de trifluoroacetato.
KR890008156A (ko) 깅콜리드의 신규 알콜시 유도체, 그 제조 방법 및 이를 함유한 치료 조성물
ATE69448T1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
MX9200651A (es) Nuevas feniletanolamino y feniletanolaminometil-tetralinas, proceso para su preparacion y composiciones farmaceuticas que las contienen
PT90840A (pt) Processo para a preparcao de 3-aminosidnoniminas substituidas e de composicoes farmaceuticas que as contem
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee